Multiple-Ascending Dose Study

NCT00892840 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Depression

Interventions

DRUG: BMS-820836
DRUG: Placebo

Sponsor

Bristol-Myers Squibb